Interleukin-2 inhibits FMS-like tyrosine kinase 3 receptor ligand (flt3L)-dependent development and function of conventional and plasmacytoid dendritic cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 6, 2011, Pages 2408-2413

  Lau Kilby, Annie W ^a   Kretz, Cosima C ^a   Pechhold, Susanne ^a   Price, Jeffrey D ^a   Dorta, Stephanie ^a   Ramos, Haydee ^b   Trinchieri, Giorgio ^c   Tarbell, Kristin V ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FMS LIKE TYROSINE KINASE 3 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MONOCYTE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL PROLIFERATION; DENDRITIC CELLS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PLASMA CELLS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

MUS;

EID: 79952308320     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1009738108     Document Type: Article

References (40)

1. Steinman RM, Nussenzweig MC (2002) Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99:351-358. (Pubitemid 34060366)
2. Darrasse-Jèze G, et al. (2009) Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 206:1853-1862.
3. Chen M, et al. (2006) Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311:1160-1164.
4. Karsunky H, Merad M, Cozzio A, Weissman IL, Manz MG (2003) Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med 198:305-313. (Pubitemid 36987855)
5. McKenna HJ, et al. (2000) Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95:3489-3497. (Pubitemid 30428482)
6. Colonna M, Trinchieri G, Liu YJ (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5:1219-1226. (Pubitemid 41057736)
7. Pulendran B, Tang H, Denning TL (2008) Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr Opin Immunol 20:61-67.
8. Liu K, et al. (2009) In vivo analysis of dendritic cell development and homeostasis. Science 324:392-397.
9. Vremec D, et al. (1997) The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur J Immunol 27:40-44. (Pubitemid 27046056)
10. Naik SH, et al. (2006) Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 7:663-671. (Pubitemid 43797348)
11. Esashi E, et al. (2008) The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28:509-520.
12. Gilliet M, et al. (2002) The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med 195:953-958. (Pubitemid 34286765)
13. Wang J, Wicker LS, Santamaria P (2009) IL-2 and its high-affinity receptor: Genetic control of immunoregulation and autoimmunity. Semin Immunol 21:363-371.
14. Yamanouchi J, et al. (2007) Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 39:329-337. (Pubitemid 46328484)
15. Tang Q, et al. (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28:687-697.
16. Segura E, Wong J, Villadangos JA (2009) Cutting edge: B220+CCR9- dendritic cells are not plasmacytoid dendritic cells but are precursors of conventional dendritic cells. J Immunol 183:1514-1517.
17. Blasius AL, et al. (2006) Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 177:3260-3265. (Pubitemid 44277845)
18. Blasius AL, Cella M, Maldonado J, Takai T, Colonna M (2006) Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 107:2474-2476. (Pubitemid 43345570)
19. Gaffen SL, Liu KD (2004) Overview of interleukin-2 function, production and clinical applications. Cytokine 28:109-123. (Pubitemid 39313082)
20. Nelson BH, Lord JD, Greenberg PD (1994) Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature 369:333-336. (Pubitemid 24159546)
21. Naik SH, et al. (2005) Cutting edge: Generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol 174:6592-6597. (Pubitemid 40705619)
22. Zhu BM, et al. (2008) Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression. Blood 112:2071-2080.
23. Hamilton-Williams EE, et al. (2009) Expression of diabetes-associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice. J Immunol 183:1533-1541.
24. Winkel KD, Kronin V, Krummel MF, Shortman K (1997) The nature of the signals regulating CD8 T cell proliferative responses to CD8alpha+ or CD8alpha- dendritic cells. Eur J Immunol 27:3350-3359. (Pubitemid 28018032)
25. Lenardo MJ (1991) Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858-861.
26. Liu K, Nussenzweig MC (2010) Origin and development of dendritic cells. Immunol Rev 234:45-54.
27. Di Rosa F (2009) T-lymphocyte interaction with stromal, bone and hematopoietic cells in the bone marrow. Immunol Cell Biol 87:20-29.
28. Bailey-Bucktrout SL, et al. (2008) Cutting edge: Central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J Immunol 180:6457-6461.
29. Irla M, et al. (2010) MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J Exp Med 207:1891-1905.
30. Trinchieri G (2010) Type I interferon: Friend or foe? J Exp Med 207:2053-2063.
31. Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307-336. (Pubitemid 40563172)
32. Li Q, et al. (2008) Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA 105:12439-12444.
33. Stewart TA, et al. (1993) Induction of type I diabetes by interferon-alpha in transgenic mice. Science 260:1942-1946. (Pubitemid 23258275)
34. Downes K, et al. (2010) Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS ONE 5:e12646.
35. Devendra D, Eisenbarth GS (2004) Interferon alpha-a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol 111:225-233. (Pubitemid 38739316)
36. Jin GH, Hirano T, Murakami M (2008) Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation. Int Immunol 20:783-789. (Pubitemid 351791522)
37. Vicari AP, Caux C, Trinchieri G (2002) Tumour escape from immune surveillance through dendritic cell inactivation. Semin Cancer Biol 12:33-42. (Pubitemid 34087896)
38. Salio M, et al. (2003) Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions. Eur J Immunol 33:1052-1062. (Pubitemid 36546693)
39. van der Vliet HJ, et al. (2007) Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer. Clin Cancer Res 13:2100-2108.
40. Jung S, et al. (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20:4106-4114. (Pubitemid 30314508)